{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:32:39Z","timestamp":1783650759606,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Xuzhou Special fund for promoting scientific and technological innovation","award":["KC23254"],"award-info":[{"award-number":["KC23254"]}]},{"name":"The Initializing Fund of Xuzhou Medical University","award":["RC20552111"],"award-info":[{"award-number":["RC20552111"]}]},{"name":"The Initializing Fund of Xuzhou Medical University","award":["RC20552222"],"award-info":[{"award-number":["RC20552222"]}]},{"DOI":"10.13039\/501100018610","name":"Innovation Program in Military Medicine of Chinese People\u2019s Liberation Army","doi-asserted-by":"publisher","award":["XYRHCX2021011"],"award-info":[{"award-number":["XYRHCX2021011"]}],"id":[{"id":"10.13039\/501100018610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Fusion Innovation Project of Xuzhou Medical University","award":["XYRHCX2022005"],"award-info":[{"award-number":["XYRHCX2022005"]}]},{"name":"The Medical Research Project of Jiangsu Provincial Health Commission","award":["Z2023010"],"award-info":[{"award-number":["Z2023010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04056-y","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T05:01:25Z","timestamp":1713589285000},"page":"3047-3055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study"],"prefix":"10.1007","volume":"56","author":[{"given":"Min","family":"Rui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-5530","authenticated-orcid":false,"given":"Dong-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"issue":"6","key":"4056_CR1","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1172\/JCI72270","volume":"124","author":"LH Beck Jr","year":"2014","unstructured":"Beck LH Jr, Salant DJ (2014) Membranous nephropathy: from models to man. J Clin Investig 124(6):2307\u20132314. https:\/\/doi.org\/10.1172\/JCI72270","journal-title":"J Clin Investig"},{"issue":"1","key":"4056_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/0886022X.2021.1914655","volume":"43","author":"H Huang","year":"2021","unstructured":"Huang H, Liang Z, Zheng X, Qing Q, Du X, Tang Z et al (2021) Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials. Ren Fail 43(1):840\u2013850. https:\/\/doi.org\/10.1080\/0886022X.2021.1914655","journal-title":"Ren Fail"},{"issue":"1","key":"4056_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-018-1011-5","volume":"19","author":"XD Zhang","year":"2018","unstructured":"Zhang XD, Cui Z, Zhang MF, Wang J, Zhang YM, Qu Z et al (2018) Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol 19(1):215. https:\/\/doi.org\/10.1186\/s12882-018-1011-5","journal-title":"BMC Nephrol"},{"issue":"1","key":"4056_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ndt\/gfr285","volume":"27","author":"N Polanco","year":"2012","unstructured":"Polanco N, Gutierrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D et al (2012) Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transpl 27(1):231\u2013234. https:\/\/doi.org\/10.1093\/ndt\/gfr285","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"4056_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2215\/CJN.01330209","volume":"4","author":"MA Hladunewich","year":"2009","unstructured":"Hladunewich MA, Troyanov S, Calafati J, Cattran DC (2009) The natural history of the non nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol CJASN 4(9):1417\u20131422. https:\/\/doi.org\/10.2215\/CJN.01330209","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"4","key":"4056_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0270-9295(03)00049-4","volume":"23","author":"RJ Glassock","year":"2003","unstructured":"Glassock RJ (2003) Diagnosis and natural course of membranous nephropathy. Semin Nephrol 23(4):324\u2013332. https:\/\/doi.org\/10.1016\/s0270-9295(03)00049-4","journal-title":"Semin Nephrol"},{"issue":"2","key":"4056_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM199307083290203","volume":"329","author":"A Schieppati","year":"1993","unstructured":"Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S et al (1993) Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329(2):85\u201389. https:\/\/doi.org\/10.1056\/NEJM199307083290203","journal-title":"N Engl J Med"},{"key":"4056_CR8","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.2147\/DDDT.S209211","volume":"13","author":"W Lin","year":"2019","unstructured":"Lin W, Li HY, Lin S, Zhou T (2019) Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis. Drug Des Dev Ther 13:2179\u20132186. https:\/\/doi.org\/10.2147\/DDDT.S209211","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"4056_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1681\/ASN.V84664","volume":"8","author":"AG Wasserstein","year":"1997","unstructured":"Wasserstein AG (1997) Membranous glomerulonephritis. J Am Soc Nephrol 8(4):664\u2013674. https:\/\/doi.org\/10.1681\/ASN.V84664","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4056_CR10","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2215\/CJN.08880813","volume":"9","author":"JA van den Brand","year":"2014","unstructured":"van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF (2014) Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 9(6):1066\u20131073. https:\/\/doi.org\/10.2215\/CJN.08880813","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"4056_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1600-6143.2004.00427.x","volume":"4","author":"MA Artz","year":"2004","unstructured":"Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF et al (2004) Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transpl 4(6):937\u2013945. https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00427.x","journal-title":"Am J Transpl"},{"issue":"4","key":"4056_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1432-2277.2005.00080.x","volume":"18","author":"AG Jardine","year":"2005","unstructured":"Jardine AG (2005) Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transpl Int 18(4):379\u2013384. https:\/\/doi.org\/10.1111\/j.1432-2277.2005.00080.x","journal-title":"Transpl Int"},{"issue":"3","key":"4056_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/ndt\/gfu306","volume":"30","author":"J Caro","year":"2015","unstructured":"Caro J, Gutierrez-Solis E, Rojas-Rivera J, Agraz I, Ramos N, Rabasco C et al (2015) Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. Nephrol Dial Transplant 30(3):467\u2013474. https:\/\/doi.org\/10.1093\/ndt\/gfu306","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"4056_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s11596-015-1480-8","volume":"35","author":"ZQ Li","year":"2015","unstructured":"Li ZQ, Hu ML, Zhang C, Wang YM (2015) Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy a meta analysis of Chinese adults. J Huazhong Univ Sci Technolog Med Sci 35(5):623\u2013628. https:\/\/doi.org\/10.1007\/s11596-015-1480-8","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"10","key":"4056_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/kjm2.12098","volume":"35","author":"XJ Zhang","year":"2019","unstructured":"Zhang XJ, Ji CF, Yuan JZ, Wang L, Zhang J, Fang W et al (2019) Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: a retrospective study. Kaohsiung J Med Sci 35(10):633\u2013639. https:\/\/doi.org\/10.1002\/kjm2.12098","journal-title":"Kaohsiung J Med Sci"},{"issue":"2","key":"4056_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3892\/etm.2018.6211","volume":"16","author":"J Di","year":"2018","unstructured":"Di J, Qian Q, Yang M, Jiang Y, Zhou H, Li M et al (2018) Efficacy and safety of long-course tacrolimus treatment for idiopathic membranous nephropathy. Exp Ther Med 16(2):979\u2013984. https:\/\/doi.org\/10.3892\/etm.2018.6211","journal-title":"Exp Ther Med"},{"issue":"1","key":"4056_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12882-018-0967-5","volume":"19","author":"SL Shang","year":"2018","unstructured":"Shang SL, Cai GY, Duan SW, Li P, Li QG, Chen XM (2018) Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy. BMC Nephrol 19(1):182. https:\/\/doi.org\/10.1186\/s12882-018-0967-5","journal-title":"BMC Nephrol"},{"issue":"1","key":"4056_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/0886022X.2017.1325371","volume":"39","author":"Q Liang","year":"2017","unstructured":"Liang Q, Li H, Xie X, Qu F, Li X, Chen J (2017) The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy. Ren Fail 39(1):512\u2013518. https:\/\/doi.org\/10.1080\/0886022X.2017.1325371","journal-title":"Ren Fail"},{"issue":"4","key":"4056_CR19","doi-asserted-by":"publisher","first-page":"e5976","DOI":"10.1590\/1414-431X20175976","volume":"50","author":"W Cui","year":"2017","unstructured":"Cui W, Lu X, Min X, Liu M, Guan S, Wang Y et al (2017) Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. Braz J Med Biol Res 50(4):e5976. https:\/\/doi.org\/10.1590\/1414-431X20175976","journal-title":"Braz J Med Biol Res"},{"key":"4056_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12882-015-0199-x","volume":"16","author":"S Liu","year":"2015","unstructured":"Liu S, Li X, Li H, Liang Q, Chen J, Chen J (2015) Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study. BMC Nephrol 16:200. https:\/\/doi.org\/10.1186\/s12882-015-0199-x","journal-title":"BMC Nephrol"},{"issue":"2","key":"4056_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/nep.12569","volume":"21","author":"R Ramachandran","year":"2016","unstructured":"Ramachandran R, Hn HK, Kumar V, Nada R, Yadav AK, Goyal A et al (2016) Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial. Nephrology (Carlton) 21(2):139\u2013146. https:\/\/doi.org\/10.1111\/nep.12569","journal-title":"Nephrology (Carlton)"},{"issue":"5\u20136","key":"4056_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000348570","volume":"91","author":"H Yuan","year":"2013","unstructured":"Yuan H, Liu N, Sun GD, Jia Y, Luo P, Miao LN (2013) Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. Pharmacology 91(5\u20136):259\u2013266. https:\/\/doi.org\/10.1159\/000348570","journal-title":"Pharmacology"},{"issue":"3","key":"4056_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MAJ.0b013e3181ca3a7d","volume":"339","author":"M Chen","year":"2010","unstructured":"Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF et al (2010) Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. Am J Med Sci 339(3):233\u2013238. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181ca3a7d","journal-title":"Am J Med Sci"},{"issue":"4","key":"4056_CR24","first-page":"584","volume":"21","author":"X Li","year":"2008","unstructured":"Li X, Lv R, He Q, Li H, Du X, Lin W et al (2008) Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria. J Nephrol 21(4):584\u2013591","journal-title":"J Nephrol"},{"key":"4056_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.611480","volume":"12","author":"DD Wang","year":"2021","unstructured":"Wang DD, Mao YZ, He SM, Chen X (2021) Analysis of time course and dose effect from metformin on body mass index in children and adolescents. Front Pharmacol 12:611480. https:\/\/doi.org\/10.3389\/fphar.2021.611480","journal-title":"Front Pharmacol"},{"issue":"9158","key":"4056_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/s0140-6736(98)07493-5","volume":"353","author":"MD Denton","year":"1999","unstructured":"Denton MD, Magee CC, Sayegh MH (1999) Immunosuppressive strategies in transplantation. Lancet 353(9158):1083\u20131091. https:\/\/doi.org\/10.1016\/s0140-6736(98)07493-5","journal-title":"Lancet"},{"issue":"8","key":"4056_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneph.2012.115","volume":"8","author":"LA Greenbaum","year":"2012","unstructured":"Greenbaum LA, Benndorf R, Smoyer WE (2012) Childhood nephrotic syndrome\u2014current and future therapies. Nat Rev Nephrol 8(8):445\u2013458. https:\/\/doi.org\/10.1038\/nrneph.2012.115","journal-title":"Nat Rev Nephrol"},{"key":"4056_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696074","volume":"12","author":"DS Kim","year":"2021","unstructured":"Kim DS, Park Y, Choi JW, Park SH, Cho ML, Kwok SK (2021) Lactobacillus acidophilus supplementation exerts a synergistic effect on tacrolimus efficacy by modulating Th17\/Treg balance in lupus-prone mice via the SIGNR3 pathway. Front Immunol 12:696074. https:\/\/doi.org\/10.3389\/fimmu.2021.696074","journal-title":"Front Immunol"},{"key":"4056_CR29","doi-asserted-by":"publisher","first-page":"32087","DOI":"10.1038\/srep32087","volume":"6","author":"X Shen","year":"2016","unstructured":"Shen X, Jiang H, Ying M, Xie Z, Li X, Wang H et al (2016) Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep 6:32087. https:\/\/doi.org\/10.1038\/srep32087","journal-title":"Sci Rep"},{"issue":"1","key":"4056_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/jcpt.13260","volume":"46","author":"X Chen","year":"2021","unstructured":"Chen X, Wang DD, Li ZP (2021) Analysis of time course and dose effect of tacrolimus on proteinuria in lupus nephritis patients. J Clin Pharm Ther 46(1):106\u2013113. https:\/\/doi.org\/10.1111\/jcpt.13260","journal-title":"J Clin Pharm Ther"},{"issue":"13","key":"4056_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","volume":"319","author":"AL Beam","year":"2018","unstructured":"Beam AL, Kohane IS (2018) Big data and machine learning in health care. JAMA 319(13):1317\u20131318. https:\/\/doi.org\/10.1001\/jama.2017.18391","journal-title":"JAMA"},{"key":"4056_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.632210","volume":"8","author":"LP Liu","year":"2021","unstructured":"Liu LP, Zhao QY, Wu J, Luo YW, Dong H, Chen ZW et al (2021) Machine learning for the prediction of red blood cell transfusion in patients during or after liver transplantation surgery. Front Med 8:632210. https:\/\/doi.org\/10.3389\/fmed.2021.632210","journal-title":"Front Med"},{"key":"4056_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.637434","volume":"7","author":"QY Zhao","year":"2020","unstructured":"Zhao QY, Liu LP, Luo JC, Luo YW, Wang H, Zhang YJ et al (2020) A machine-learning approach for dynamic prediction of sepsis-induced coagulopathy in critically Ill patients with sepsis. Front Med 7:637434. https:\/\/doi.org\/10.3389\/fmed.2020.637434","journal-title":"Front Med"},{"key":"4056_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.694520","volume":"8","author":"Y Hirano","year":"2021","unstructured":"Hirano Y, Shinmoto K, Okada Y, Suga K, Bombard J, Murahata S et al (2021) Machine learning approach to predict positive screening of methicillin\u2013resistant Staphylococcus aureus during mechanical ventilation using synthetic dataset from mimic-iv database. Front Med 8:694520. https:\/\/doi.org\/10.3389\/fmed.2021.694520","journal-title":"Front Med"},{"issue":"4","key":"4056_CR35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.kint.2020.10.014","volume":"99","author":"G Fernandez-Juarez","year":"2021","unstructured":"Fernandez-Juarez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontan F et al (2021) The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. Kidney Int 99(4):986\u2013998. https:\/\/doi.org\/10.1016\/j.kint.2020.10.014","journal-title":"Kidney Int"},{"issue":"9","key":"4056_CR36","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/sj.ki.5002215","volume":"71","author":"M Praga","year":"2007","unstructured":"Praga M, Barrio V, Juarez GF, Luno J (2007) Tacrolimus monotherapy in membranous nephropathy a randomized controlled trial. Kidney Int 71(9):924\u2013930. https:\/\/doi.org\/10.1038\/sj.ki.5002215","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04056-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:33:51Z","timestamp":1723563231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04056-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["4056"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04056-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"27 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}